As of November 15, 2026, Cero Therapeutics Holdings, Inc. is a publicly traded company (OTC: CERO). No bankruptcy or receivership appears in its SEC Form 8-K filings (Schedule 13G, March 12, 2026).
Is this your company?
About to sign with, pay or invest in Cero Therapeutics Holdings, Inc.? See the free Snapshot first.
Free to see. No signup.
Is Cero Therapeutics Holdings, Inc. a real, registered company?
- Cero Therapeutics Holdings, Inc. files with the SEC under CIK 1870404 (its SEC filings).
- Its shares are listed under the ticker CERO on OTC (also CEROW) (SEC company record).
- Incorporated in Delaware; business address in South San Francisco, California, as its SEC filings state.
- Court and bankruptcy records: see Before you sign or pay below.
Before you sign or pay
- Court and bankruptcy: No federal court case or bankruptcy filing found under CERO THERAPEUTICS HOLDINGS, INC. in our court records and SEC 8-K records (as of 2026-11-15).
- Leadership changes: the latest reported is Eric Francois, Director (Form 8-K filed 2026-02-13). Check you are dealing with the people now in charge.
- Ownership: 5%+ holders are reported on Schedule 13D or 13G; the latest names Tibbs Isaiah (filed 2026-03-12).
Who are Cero Therapeutics Holdings, Inc.'s owners and officers?
Cero Therapeutics Holdings, Inc.: incorporated in Delaware; business address in South San Francisco, California; industry Biological Products, (No Diagnostic Substances) (Schedule 13G/A, 2026-08-14).
Officers and directors, each with the role and the filing that names them:
- : Executive Officer, Director (Form D, 2025-05-06)
- : Executive Officer (Form D, 2025-05-06)
- : Executive Officer (Form D, 2025-05-06)
- : Director (Form D, 2025-05-06)
- : Director (Form D, 2025-05-06)
- : Director (Form D, 2025-05-06)
- : Director (Form D, 2025-05-06)
- : Director (Form D, 2025-05-06)
| Report | Holder | Share |
|---|---|---|
| Schedule 13G/A, 2026-08-14 | Tibbs Isaiah | 4.63% |
| Schedule 13G, 2026-03-12 | Tibbs Isaiah | 8.67% |
| Schedule 13G/A, 2025-08-14 | Armistice Capital, LLC | 4.99% |
Want the whole picture on Cero Therapeutics Holdings, Inc.?
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Cero Therapeutics Holdings, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Cero Therapeutics Holdings, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
13 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
| Filed | Person | Role | Change | Effective |
|---|---|---|---|---|
| Form 8-K, 2026-02-13 | Eric Francois | Director | appointed | 2026-02-13 |
How much has Cero Therapeutics Holdings, Inc. raised?
| Filed | Sold | Offered |
|---|---|---|
| Form D, 2025-05-06 | $5M | $8M |
| Form D, 2024-10-04 | $1.25M | $1.25M |
| Form D, 2024-02-23 | $10.19M | $10.19M |
Latest IPO step: Cero Therapeutics Holdings, Inc. filed to go public (S-1, 2025-12-05).
IPO filings: S-1, 2025-12-05, S-1, 2025-07-21, S-1/A, 2025-02-05, S-1/A, 2025-01-21, S-1, 2024-12-23.
Keep reading
More on Cero Therapeutics Holdings, Inc. and the records around it.
Cero Therapeutics Holdings, Inc. elsewhere on the record
- Leadership changes Feb 2026
- IPO filing Dec 2025
- Form D filing May 2025
Companies that share a holder
- Armistice Capital, LLC also filed stake reports on 120 other companies: Autolus Therapeutics plc (Aug 2026), Bicycle Therapeutics plc (Aug 2026), BioXcel Therapeutics, Inc. (Aug 2026)
Related pages
Leadership changes5%+ holdersIPO filings
Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.
Not for employment, credit, insurance or tenancy decisions.
Cite this page
https://mentionfox.com/who-owns/cero-therapeutics